Retatrutide is a novel triple agonist targeting glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. This innovative peptide formulation offers dual benefits for metabolic health management.
Primary Applications:
1. Blood glucose regulation in adults with type 2 diabetes mellitus
2. Long-term weight management support for overweight individuals with obesity or weight-related comorbidities
Quality Assurance:
Each batch undergoes rigorous HPLC-MS analysis to ensure consistent purity and potency. Our manufacturing process complies with cGMP standards for pharmaceutical peptides.
Storage Recommendations:
For optimal stability, store unopened vials at 2-8°C in their original packaging. Protect from light and moisture. The product maintains stability for 24 months when stored properly.
Research Applications:
This compound is intended for laboratory research purposes only. Not for human consumption. Researchers should handle all peptides using proper laboratory safety protocols.